Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Amyotonia Congenita

fluorodeoxyglucose f18 has been researched along with Amyotonia Congenita in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauckneht, M; Bellini, A; Beltrametti, MC; Buschiazzo, A; Cabona, C; Calamia, I; Calvo, A; Campi, C; Canosa, A; Capitanio, S; Caponnetto, C; Chiò, A; Cistaro, A; Fania, P; Mancardi, G; Margotti, S; Marini, C; Massone, A; Moglia, C; Morbelli, S; Nobili, F; Piana, M; Piva, R; Poggi, I; Sambuceti, G1
Hahn, K; Pfluger, T1
Brooks, RA; Dalakas, MC; Di Chiro, G; Hatazawa, J1

Other Studies

3 other study(ies) available for fluorodeoxyglucose f18 and Amyotonia Congenita

ArticleYear
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis.
    Brain : a journal of neurology, 2018, 08-01, Volume: 141, Issue:8

    Topics: Adult; Amyotrophic Lateral Sclerosis; Brain; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuromuscular Diseases; Positron-Emission Tomography; Spinal Cord; Spine

2018
Has PET become an important clinical tool in paediatric imaging?
    European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:5

    Topics: Cardiovascular Diseases; Child; Child, Preschool; Fluorodeoxyglucose F18; Humans; Infant; Infant, Newborn; Neoplasms; Neuromuscular Diseases; Pediatrics; Positron-Emission Tomography; Radiopharmaceuticals

2004
Lowered cerebral glucose utilization in amyotrophic lateral sclerosis.
    Annals of neurology, 1987, Volume: 22, Issue:5

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Brain; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Motor Neurons; Neuromuscular Diseases; Tomography, Emission-Computed

1987